Blue Zone Wealth Advisors LLC Has $4.96 Million Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

Blue Zone Wealth Advisors LLC increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 66.1% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 16,538 shares of the medical instruments supplier’s stock after purchasing an additional 6,579 shares during the period. West Pharmaceutical Services accounts for approximately 1.5% of Blue Zone Wealth Advisors LLC’s holdings, making the stock its 28th largest position. Blue Zone Wealth Advisors LLC’s holdings in West Pharmaceutical Services were worth $4,964,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Pitcairn Co. increased its stake in shares of West Pharmaceutical Services by 3.4% during the 1st quarter. Pitcairn Co. now owns 875 shares of the medical instruments supplier’s stock worth $346,000 after purchasing an additional 29 shares during the last quarter. Clearbridge Investments LLC lifted its holdings in shares of West Pharmaceutical Services by 0.7% in the 1st quarter. Clearbridge Investments LLC now owns 4,495 shares of the medical instruments supplier’s stock worth $1,779,000 after acquiring an additional 31 shares during the last quarter. RFG Advisory LLC lifted its stake in West Pharmaceutical Services by 2.3% in the first quarter. RFG Advisory LLC now owns 1,465 shares of the medical instruments supplier’s stock worth $580,000 after purchasing an additional 33 shares during the last quarter. Ballentine Partners LLC boosted its holdings in West Pharmaceutical Services by 4.7% during the 2nd quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 33 shares during the period. Finally, Wallace Advisory Group LLC grew its holdings in shares of West Pharmaceutical Services by 4.5% in the first quarter. Wallace Advisory Group LLC now owns 957 shares of the medical instruments supplier’s stock worth $379,000 after purchasing an additional 41 shares during the last quarter. 93.90% of the stock is owned by institutional investors.

West Pharmaceutical Services Price Performance

WST stock opened at $290.63 on Tuesday. The firm’s 50-day moving average price is $301.44 and its two-hundred day moving average price is $330.93. The stock has a market capitalization of $21.08 billion, a price-to-earnings ratio of 38.34, a PEG ratio of 10.57 and a beta of 1.01. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a 12-month low of $265.00 and a 12-month high of $413.70.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The business had revenue of $702.10 million for the quarter, compared to the consensus estimate of $729.36 million. West Pharmaceutical Services’s revenue was down 6.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.11 EPS. As a group, equities analysts predict that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current year.

Insider Buying and Selling

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of West Pharmaceutical Services stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the sale, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.53% of the stock is owned by insiders.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.